-
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
Emergency medicine physicians routinely manage patients with neurologic toxicity due to drugs and chemicals. The causes of these toxicities are diverse. The focus of this article will be on the manifestations of drugs in the CNS, along with management recommendations.
-
-
Organizations unveil patient safety road map; PA state legislature puts patient safety in spotlight
-
Increase in Blood Glucose Concentration During Antihypertensive
Treatment as a Predictor of Myocardial Infarction; Adverse Drug Events
in Ambulatory Care; Prevention of Hip Fracture by External Hip
Protectors; Rapid MRI vs Radiographs for Patients with Low Back Pain;
Effectiveness of Anticholinergic Drugs Compared with Placebo in the
Treatment of Overactive Bladder; A Randomized Trial of a Low
Carbohydrate Diet for Obesity
-
Nasally Administered Flu Vaccine Comes to United States; Paxil: Not
Recommended for Children; Prilosec Granted OTC Status; Finasteride and
Prostate Cancer; Xolair: First Biologic Agent for Asthma; West Nile
Virus Update; Study Shows COX-2 Inhibitors Appear Safe with Aspirin in
Asthma Patients; Lamictal Approved for Bipolar Disorder
-
Among 54 patients with essential hyperhidrosis, 24 underwent T2/T3 sympathicotomy and were compared to 30 subsequent patients treated by selective T3 sympathicotomy.
-
Among 359 patients with bladder cancer confirmed by tissue diagnosis and seen between 1962 and 2001 at the University of Kentucky Medical Center, 14% (n = 52) developed neurological complications.
-
In this report by Klein and colleagues, the clinical features of a series of 18 patients evaluated at the Mayo Clinic for autonomic dysfunction are presented.